Illustration: Annelise Capossela/Axios
Helical raised a $10 million seed round to expand its virtual AI platform for drug discovery, CEO Rick Schneider tells Axios Pro exclusively.
Why it matters: Pharma companies are racing to cut early-stage drug development risk, as R&D costs continue to rise.
